ACAD ACADIA PHARMACEUTICALS INC

Ownership history in Virtu Financial LLC  ·  11 quarters on record

This page tracks every 13F SEC filing in which Virtu Financial LLC reported a position in ACADIA PHARMACEUTICALS INC (ACAD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.13% (2019 Q3)
Avg. % of fund
0.06%
First filed
2018 Q4
Last filed
2025 Q3
Quarters held
11
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 32,815 +18,103 +123.0% 0.04% $700K $21.34
2024 Q2 REDUCED 14,712 -700 -4.5% 0.02% $239K $16.25
2024 Q1 ADDED 15,412 +58 +0.4% 0.02% $285K $18.49
2022 Q2 REDUCED 15,354 -29,626 -65.9% 0.02% $216K $14.09
2021 Q4 REDUCED 44,980 -2,209 -4.7% 0.11% $1.1M $23.34
2021 Q2 ADDED 47,189 +34,904 +284.1% 0.11% $1.2M $24.39
2020 Q2 REDUCED 12,285 -8,316 -40.4% 0.07% $595K $48.47
2019 Q4 REDUCED 20,601 -25,513 -55.3% 0.09% $881K $42.78
2019 Q3 ADDED 46,114 +27,387 +146.2% 0.13% $1.7M $35.99
2019 Q1 REDUCED 18,727 -4,248 -18.5% 0.03% $503K $26.85
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ACAD price (monthly, adj. close)
← Back to Virtu Financial LLC Holdings